BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kupcinskaite-Noreikiene R, Ugenskiene R, Noreika A, Rudzianskas V, Gedminaite J, Skieceviciene J, Juozaityte E. Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach. BMC Cancer 2016;16:40. [PMID: 26810771 DOI: 10.1186/s12885-016-2077-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ignatavicius P, Dauksa A, Zilinskas J, Kazokaite M, Riauka R, Barauskas G. DNA Methylation of HOXA11 Gene as Prognostic Molecular Marker in Human Gastric Adenocarcinoma. Diagnostics 2022;12:1686. [DOI: 10.3390/diagnostics12071686] [Reference Citation Analysis]
2 Cao Y, Tu Y, Xiong J, Tan S, Luo L, Wu A, Shu X, Jie Z, Li Z. microRNA-15b-5p encapsulated by M2 macrophage-derived extracellular vesicles promotes gastric cancer metastasis by targeting BRMS1 and suppressing DAPK1 transcription. J Exp Clin Cancer Res 2022;41:152. [PMID: 35449111 DOI: 10.1186/s13046-022-02356-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhu M, Liang Q, Chen T, Kong Q, Ye G, Yu S, Li X, He Q, Liu H, Hu Y, Yu J, Li G. Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer. Clin Epigenetics 2021;13:22. [PMID: 33514440 DOI: 10.1186/s13148-020-00989-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Baba H, Kanda M, Sato Y, Sawaki K, Shimizu D, Koike M, Motoyama S, Kodera Y, Fujii T. Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2020;27:3247-56. [PMID: 32253672 DOI: 10.1245/s10434-020-08431-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Samadani AA, Noroollahi SE, Mansour-ghanaei F, Rashidy-pour A, Joukar F, Bandegi AR. Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect? Biomedicine & Pharmacotherapy 2019;109:144-56. [DOI: 10.1016/j.biopha.2018.10.094] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
6 Shen S, Chen X, Li H, Sun L, Yuan Y. MLH1 Promoter Methylation and Prediction/Prognosis of Gastric Cancer: A Systematic Review and Meta and Bioinformatic Analysis. J Cancer 2018;9:1932-42. [PMID: 29896277 DOI: 10.7150/jca.23284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 Wen J, Zheng T, Hu K, Zhu C, Guo L, Ye G. Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection. Oncotarget. 2017;8:77783-77793. [PMID: 29100425 DOI: 10.18632/oncotarget.20782] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
8 Padmanabhan N, Ushijima T, Tan P. How to stomach an epigenetic insult: the gastric cancer epigenome. Nat Rev Gastroenterol Hepatol 2017;14:467-78. [PMID: 28513632 DOI: 10.1038/nrgastro.2017.53] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 15.3] [Reference Citation Analysis]
9 Yu D, Cao T, Han YD, Huang FS. Relationships between MGMT promoter methylation and gastric cancer: a meta-analysis. Onco Targets Ther 2016;9:6049-57. [PMID: 27785051 DOI: 10.2147/OTT.S114052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]